These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 15719095)

  • 1. "Uncorking" of liposomes by matrix metalloproteinase-9.
    Sarkar NR; Rosendahl T; Krueger AB; Banerjee AL; Benton K; Mallik S; Srivastava DK
    Chem Commun (Camb); 2005 Feb; (8):999-1001. PubMed ID: 15719095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinase-assisted triggered release of liposomal contents.
    Sarkar N; Banerjee J; Hanson AJ; Elegbede AI; Rosendahl T; Krueger AB; Banerjee AL; Tobwala S; Wang R; Lu X; Mallik S; Srivastava DK
    Bioconjug Chem; 2008 Jan; 19(1):57-64. PubMed ID: 18078309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanistic studies of the triggered release of liposomal contents by matrix metalloproteinase-9.
    Elegbede AI; Banerjee J; Hanson AJ; Tobwala S; Ganguli B; Wang R; Lu X; Srivastava DK; Mallik S
    J Am Chem Soc; 2008 Aug; 130(32):10633-42. PubMed ID: 18642903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasound enhanced matrix metalloproteinase-9 triggered release of contents from echogenic liposomes.
    Nahire R; Paul S; Scott MD; Singh RK; Muhonen WW; Shabb J; Gange KN; Srivastava DK; Sarkar K; Mallik S
    Mol Pharm; 2012 Sep; 9(9):2554-64. PubMed ID: 22849291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel PEG-matrix metalloproteinase-2 cleavable peptide-lipid containing galactosylated liposomes for hepatocellular carcinoma-selective targeting.
    Terada T; Iwai M; Kawakami S; Yamashita F; Hashida M
    J Control Release; 2006 Apr; 111(3):333-42. PubMed ID: 16488046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-hematin interaction with the hemopexin domain of gelatinase B/MMP-9 provokes autocatalytic processing of the propeptide, thereby priming activation by MMP-3.
    Geurts N; Martens E; Van Aelst I; Proost P; Opdenakker G; Van den Steen PE
    Biochemistry; 2008 Feb; 47(8):2689-99. PubMed ID: 18237197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Release of liposomal contents by cell-secreted matrix metalloproteinase-9.
    Banerjee J; Hanson AJ; Gadam B; Elegbede AI; Tobwala S; Ganguly B; Wagh AV; Muhonen WW; Law B; Shabb JB; Srivastava DK; Mallik S
    Bioconjug Chem; 2009 Jul; 20(7):1332-9. PubMed ID: 19601658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effect of matrix metalloproteinase inhibitors against epidermal basement membrane damage: skin equivalents partially mimic photoageing process.
    Amano S; Ogura Y; Akutsu N; Matsunaga Y; Kadoya K; Adachi E; Nishiyama T
    Br J Dermatol; 2005 Dec; 153 Suppl 2():37-46. PubMed ID: 16280020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of photocleavable lipids and their application in liposomal "uncorking".
    Chandra B; Mallik S; Srivastava DK
    Chem Commun (Camb); 2005 Jun; (24):3021-3. PubMed ID: 15959571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting neutrophil collagenase/matrix metalloproteinase-8 and gelatinase B/matrix metalloproteinase-9 with a peptidomimetic inhibitor protects against endotoxin shock.
    Hu J; Van den Steen PE; Dillen C; Opdenakker G
    Biochem Pharmacol; 2005 Aug; 70(4):535-44. PubMed ID: 15992779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory profiles of captopril on matrix metalloproteinase-9 activity.
    Yamamoto D; Takai S; Miyazaki M
    Eur J Pharmacol; 2008 Jul; 588(2-3):277-9. PubMed ID: 18501888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of matrix metalloproteinase-9 by "multi-prong" surface binding groups.
    Banerjee AL; Tobwala S; Haldar MK; Swanson M; Roy BC; Mallik S; Srivastava DK
    Chem Commun (Camb); 2005 May; (20):2549-51. PubMed ID: 15900322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protease yoga: extreme flexibility of a matrix metalloproteinase.
    Overall CM; Butler GS
    Structure; 2007 Oct; 15(10):1159-61. PubMed ID: 17937904
    [No Abstract]   [Full Text] [Related]  

  • 14. Plasma storage at -80 degrees C does not protect matrix metalloproteinase-9 from degradation.
    Rouy D; Ernens I; Jeanty C; Wagner DR
    Anal Biochem; 2005 Mar; 338(2):294-8. PubMed ID: 15745750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temperature-sensitive poly(N-(2-hydroxypropyl)methacrylamide mono/dilactate)-coated liposomes for triggered contents release.
    Paasonen L; Romberg B; Storm G; Yliperttula M; Urtti A; Hennink WE
    Bioconjug Chem; 2007; 18(6):2131-6. PubMed ID: 17963354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of extracellular matrix-degrading proteases matrix metalloproteinases 3 and 9 on spatial learning and synaptic plasticity.
    Meighan SE; Meighan PC; Choudhury P; Davis CJ; Olson ML; Zornes PA; Wright JW; Harding JW
    J Neurochem; 2006 Mar; 96(5):1227-41. PubMed ID: 16464240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gelatinase B [matrix metalloproteinase (MMP)-9] and collagenases (MMP-8/-13) are upregulated in cerebrospinal fluid during aseptic and bacterial meningitis in children.
    Lindberg RL; Sorsa T; Tervahartiala T; Hoffmann F; Mellanen L; Kappos L; Schaad UB; Leib SL; Leppert D
    Neuropathol Appl Neurobiol; 2006 Jun; 32(3):304-17. PubMed ID: 16640649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological and pathobiological functions of gelatinase dimers and complexes.
    Malla N; Sjøli S; Winberg JO; Hadler-Olsen E; Uhlin-Hansen L
    Connect Tissue Res; 2008; 49(3):180-4. PubMed ID: 18661338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoactivation profiles of calcium-dependent matrix metalloproteinase-2 and -9 in inflammatory synovial fluid: effect of pyrophosphate and bisphosphonates.
    Makowski GS; Ramsby ML
    Clin Chim Acta; 2005 Aug; 358(1-2):182-91. PubMed ID: 15921672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of matrix metalloproteinase-2 and -9 and contents of their tissue inhibitors in uterine leiomyoma and corresponding myometrium.
    Bogusiewicz M; Stryjecka-Zimmer M; Postawski K; Jakimiuk AJ; Rechberger T
    Gynecol Endocrinol; 2007 Sep; 23(9):541-6. PubMed ID: 17943549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.